Drugs / Lipopolysaccharides
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06270576 Comparator | Apr 2024 → Apr 2028 expected | asthma | National Jewish Health | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lipopolysaccharides | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06270576 ↗ |
| Route | Intranasal | “intranasal administration of endotoxin” NCT06270576 ↗ |